Tramadol HCL ER

FDA Drug Profile — Tramadol HCL ER

Drug Details

Generic Name
Tramadol HCL ER
Brand Names
Tramadol HCL ER
Application Number
ANDA200503
Sponsor
Direct_Rx
NDC Codes
1
Dosage Forms
TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
TRAMADOL HYDROCHLORIDE

Indications and Usage

Tramadol hydrochloride extended-release tablet is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosages or duration, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Tramadol hydrochloride extended-release tablets is not indicated as an as-needed (prn) analgesic.